CROSS
发表于 2025-3-21 19:50:56
书目名称Biologics in General Medicine影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0187535<br><br> <br><br>书目名称Biologics in General Medicine读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0187535<br><br> <br><br>
STYX
发表于 2025-3-22 00:08:54
Infliximab: From the Idea to the Productle and membrane- bound TNF-α . Infliximab does not bind to TNF-β (lymphotoxin α ), a related cytokine that utilizes the same receptors as TNF-α. Thus infliximab was developed as a therapeutic agent for various inflammatory chronic diseases that are believed to be driven by the pro-inflammatory cytok
Factorable
发表于 2025-3-22 04:08:51
http://reply.papertrans.cn/19/1876/187535/187535_3.png
Ischemia
发表于 2025-3-22 05:16:01
http://reply.papertrans.cn/19/1876/187535/187535_4.png
Anemia
发表于 2025-3-22 10:45:40
http://reply.papertrans.cn/19/1876/187535/187535_5.png
incite
发表于 2025-3-22 16:14:15
http://reply.papertrans.cn/19/1876/187535/187535_6.png
macular-edema
发表于 2025-3-22 21:05:54
The Production of Biopharmaceuticals chemical synthesis, biologics are made by biosynthesis in living cells. Biologics are generally much larger than traditional synthetic medicinal products and range from highly complex inactivated vaccines and plasma-derived factors to highly purified, well characterised recombinant therapeutic prot
埋葬
发表于 2025-3-22 22:48:34
Treating Autoimmune Bullous Skin Disorders with Biologicsng distinct adhesionmolecules of the epidermis and dermoepidermal basement membrane zone leading to a loss of adhesive function of the target antigen(s) (Fig. 8.1). The appearance of blisters and erosions of the skin and/or mucous membranes is the leading clinical sign of autoimmune bullous skin dis
prediabetes
发表于 2025-3-23 02:44:21
Biologics in Psoriasisune mediated inflammatory changes seen in psoriasis have been elucidated, leading to the development of biologics that specifically act on immunological mechanisms, which are thought to be pathogenic in psoriatic lesions. By acting on specific immunological actions in the large cascade that results
projectile
发表于 2025-3-23 09:09:32
Biologic Agents in Psoriatic Arthritisof the population, although estimates of its prevalence vary widely, and is generally considered an autoimmune disease with unknown antigenic determinants. There currently is no predictive marker indicating which psoriasis patients will develop arthritis (Mease 2004). PsA often is classified as a su